Evolution of and risk factors for psychological distress in patients with psoriasis: The psychae study

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 1, 2010, Pages 297-306

  Colombo, D ^a   Caputo, A ^b   Finzi, A ^a   Andreassi, L ^c,d   Chimenti, S ^g   Vena, G A ^e   Giannetti, A ^f  

^a Marchesi Hospital   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g NONE

Author keywords

Coping; Psoriasis; Psychological distress

Indexed keywords

COLECALCIFEROL; CYCLOSPORIN; METHOTREXATE; STEROID;

ADULT; ARTICLE; BEHAVIORAL SCIENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISTRESS SYNDROME; FEMALE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; QUESTIONNAIRE; RISK FACTOR;

EID: 77951763432     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300128     Document Type: Article

References (31)

1. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 2004; 45:155-159
2. Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45:72-76 (Pubitemid 32655696)
3. Griffiths CE, Richards HL. Psychological influences in psoriasis. Clin Exp Dermatol 2001; 26:338-342
4. O'Leary CJ, Creamer D, Higgins E, Weinman J. Perceived stress, stress attributions and psychological distress in psoriasis. J Psychosom Res 2004; 57:465-71. (Pubitemid 39577639)
5. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004; 18:27-36. (Pubitemid 38159357)
6. Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, Main CJ, Griffiths CE. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139:752-756 (Pubitemid 36705942)
7. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003; 4:833-842 (Pubitemid 38030859)
8. Kulkarni AS, Balkrishnan R, Camacho FT, Anderson RT, Feldman SR. Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol 2004; 3:661-6.
9. Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HG. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 2000; 142:899-907. (Pubitemid 30304599)
10. Fortune DG, Richards HL, Kirby B, McElhone K, Main CJ, Griffiths CE. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol 2004; 151:1219-1226 (Pubitemid 40030170)
11. Finzi A, Colombo D, Caputo A, Andreassi L, Chimenti S, Vena G, Simoni L, Sgarbi S, Giannetti A: PSYCHAE Study Group. Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol 2007; 21:1161-1169 (Pubitemid 47423402)
12. Colangelo PM, Welch DW, Rich DS, Jeffrey LP. Two methods for estimating body surface area in adult amputees. Am J Hosp Pharm 1984; 41:2650-2655
13. Bellantuono C, Fiorio R, Zanotelli R, Tansella M. Psychiatric screening in general practice in Italy. A validity study of the GHQ (General Health Questionnaire). Soc Psychiatry 1987; 22:113-117
14. Piccinelli M, Bisoffi G, Bon MG, Cunico L, Tansella M. Validity and test-retest reliability of the Italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods. Compr Psychiatry 1993; 34:198-205. (Pubitemid 23170659)
15. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13:595-605. (Pubitemid 13019024)
16. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997; 4:92-100.
17. Skrondal A, Rabe-Hesketh S. Generalized latent variable modeling: multilevel, longitudinal, and structural equation models. Chapman & Hal. Boca Raton, 2004.
18. Menter A, Griffiths CE. Current and future management of psoriasis. Lancet 2007; 370:272-284
19. Griffiths CE, Dubertret L, Ellis CN, et al. Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol 2004; 150(S):11-23. (Pubitemid 38903574)
20. Griffiths CE, Katsambas A, Dijkmans BA, Finlay AY, Ho VC, Johnston A, Luger TA, Mrowietz U, Thestrup-Pedersen K. Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol 2006; 155(S):1-16. (Pubitemid 43855773)
21. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137:280-284
22. Schmitt J, Ford DE. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach. Gen Hosp Psychiatry 2007; 29:134-140
23. Sampogna F, Tabolli S, Mastroeni S, Di Pietro C, Fortes C, Abeni D: Italian Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) study group Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology 2007; 215:341-347
24. Eghlileb AM, Davies EE, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007; 156:1245-1250
25. Zalewska A, Miniszewska J, Chodkiewicz J, Narbutt J. Acceptance of chronic illness in psoriasis vulgaris patients. J Eur Acad Dermatol Venereol 2007; 21:235-242 (Pubitemid 46128700)
26. Rapp SR, Cottrell CA, Leary MR. Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol 2001; 145:610-616
27. Consoli SM, Rolhion S, Martin C, Ruel K, Cambazard F, Pellet J, Misery L. Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology 2006; 212:128-136
28. Keinan G, Segal A, Gal U, Brenner S. Stress management for psoriasis patients: the effectiveness of biofeedback and relaxation techniques. Stress Medicine 1994:235-241
29. Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CE. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 2002; 146:458-465
30. Tausk F, Whitmore SE. A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother Psychosom 1999; 68:221-225
31. Vedhara K, Morris RM, Booth R, Horgan M, Lawrence M, Birchall N. Changes in mood predict disease activity and quality of life in patients with psoriasis following emotional disclosure. J Psychosom Res 2007; 62:611-619